Global Piroxicam Market Growth (Status and Outlook) 2025-2031
According to this study, the global Piroxicam market size will reach US$ million by 2031.
A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.
United States market for Piroxicam is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Piroxicam is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Piroxicam is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Piroxicam players cover Pfizer, Teva, Mylan, Nostrum, DCPC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Piroxicam Industry Forecast” looks at past sales and reviews total world Piroxicam sales in 2024, providing a comprehensive analysis by region and market sector of projected Piroxicam sales for 2025 through 2031. With Piroxicam sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Piroxicam industry.
This Insight Report provides a comprehensive analysis of the global Piroxicam landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Piroxicam portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Piroxicam market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Piroxicam and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Piroxicam.
This report presents a comprehensive overview, market shares, and growth opportunities of Piroxicam market by product type, application, key players and key regions and countries.
Segmentation by Type:
A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.
United States market for Piroxicam is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Piroxicam is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Piroxicam is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Piroxicam players cover Pfizer, Teva, Mylan, Nostrum, DCPC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Piroxicam Industry Forecast” looks at past sales and reviews total world Piroxicam sales in 2024, providing a comprehensive analysis by region and market sector of projected Piroxicam sales for 2025 through 2031. With Piroxicam sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Piroxicam industry.
This Insight Report provides a comprehensive analysis of the global Piroxicam landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Piroxicam portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Piroxicam market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Piroxicam and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Piroxicam.
This report presents a comprehensive overview, market shares, and growth opportunities of Piroxicam market by product type, application, key players and key regions and countries.
Segmentation by Type:
- by Dosage Form
- by Route
- Tendonitis
- Systemic Traumatic Pain
- Musculoskeletal Pain
- Contraception
- Rheumatoid Arthritis
- Chronic Infectious Arthritis
- Osteoarthritis
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Teva
- Mylan
- Nostrum
- DCPC
- FANGMING
- JINGHUA
- JUMPCAN
- Technilab Pharma
- Apotex Corporation
- Keltman Pharmaceuticals
- Genpharm
- Bayer
- PLX Pharma
- Chiesi
- SK Chemicals
- Bioglan Laboratories
- APR
- CJ HealthCare
- SkyePharma
- Changzhou Siyao Pharmaceutical
- Shanxi Yunpeng Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Piroxicam Market Size (2020-2031)
2.1.2 Piroxicam Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Piroxicam by Country/Region (2020, 2024 & 2031)
2.2 Piroxicam Segment by Type
2.2.1 by Dosage Form
2.2.2 by Route
2.3 Piroxicam Market Size by Type
2.3.1 Piroxicam Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Piroxicam Market Size Market Share by Type (2020-2025)
2.4 Piroxicam Segment by Application
2.4.1 Tendonitis
2.4.2 Systemic Traumatic Pain
2.4.3 Musculoskeletal Pain
2.4.4 Contraception
2.4.5 Rheumatoid Arthritis
2.4.6 Chronic Infectious Arthritis
2.4.7 Osteoarthritis
2.4.8 Other
2.5 Piroxicam Market Size by Application
2.5.1 Piroxicam Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Piroxicam Market Size Market Share by Application (2020-2025)
3 PIROXICAM MARKET SIZE BY PLAYER
3.1 Piroxicam Market Size Market Share by Player
3.1.1 Global Piroxicam Revenue by Player (2020-2025)
3.1.2 Global Piroxicam Revenue Market Share by Player (2020-2025)
3.2 Global Piroxicam Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PIROXICAM BY REGION
4.1 Piroxicam Market Size by Region (2020-2025)
4.2 Global Piroxicam Annual Revenue by Country/Region (2020-2025)
4.3 Americas Piroxicam Market Size Growth (2020-2025)
4.4 APAC Piroxicam Market Size Growth (2020-2025)
4.5 Europe Piroxicam Market Size Growth (2020-2025)
4.6 Middle East & Africa Piroxicam Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Piroxicam Market Size by Country (2020-2025)
5.2 Americas Piroxicam Market Size by Type (2020-2025)
5.3 Americas Piroxicam Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Piroxicam Market Size by Region (2020-2025)
6.2 APAC Piroxicam Market Size by Type (2020-2025)
6.3 APAC Piroxicam Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Piroxicam Market Size by Country (2020-2025)
7.2 Europe Piroxicam Market Size by Type (2020-2025)
7.3 Europe Piroxicam Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Piroxicam by Region (2020-2025)
8.2 Middle East & Africa Piroxicam Market Size by Type (2020-2025)
8.3 Middle East & Africa Piroxicam Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PIROXICAM MARKET FORECAST
10.1 Global Piroxicam Forecast by Region (2026-2031)
10.1.1 Global Piroxicam Forecast by Region (2026-2031)
10.1.2 Americas Piroxicam Forecast
10.1.3 APAC Piroxicam Forecast
10.1.4 Europe Piroxicam Forecast
10.1.5 Middle East & Africa Piroxicam Forecast
10.2 Americas Piroxicam Forecast by Country (2026-2031)
10.2.1 United States Market Piroxicam Forecast
10.2.2 Canada Market Piroxicam Forecast
10.2.3 Mexico Market Piroxicam Forecast
10.2.4 Brazil Market Piroxicam Forecast
10.3 APAC Piroxicam Forecast by Region (2026-2031)
10.3.1 China Piroxicam Market Forecast
10.3.2 Japan Market Piroxicam Forecast
10.3.3 Korea Market Piroxicam Forecast
10.3.4 Southeast Asia Market Piroxicam Forecast
10.3.5 India Market Piroxicam Forecast
10.3.6 Australia Market Piroxicam Forecast
10.4 Europe Piroxicam Forecast by Country (2026-2031)
10.4.1 Germany Market Piroxicam Forecast
10.4.2 France Market Piroxicam Forecast
10.4.3 UK Market Piroxicam Forecast
10.4.4 Italy Market Piroxicam Forecast
10.4.5 Russia Market Piroxicam Forecast
10.5 Middle East & Africa Piroxicam Forecast by Region (2026-2031)
10.5.1 Egypt Market Piroxicam Forecast
10.5.2 South Africa Market Piroxicam Forecast
10.5.3 Israel Market Piroxicam Forecast
10.5.4 Turkey Market Piroxicam Forecast
10.6 Global Piroxicam Forecast by Type (2026-2031)
10.7 Global Piroxicam Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Piroxicam Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Piroxicam Product Offered
11.1.3 Pfizer Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Piroxicam Product Offered
11.2.3 Teva Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Piroxicam Product Offered
11.3.3 Mylan Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Nostrum
11.4.1 Nostrum Company Information
11.4.2 Nostrum Piroxicam Product Offered
11.4.3 Nostrum Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Nostrum Main Business Overview
11.4.5 Nostrum Latest Developments
11.5 DCPC
11.5.1 DCPC Company Information
11.5.2 DCPC Piroxicam Product Offered
11.5.3 DCPC Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 DCPC Main Business Overview
11.5.5 DCPC Latest Developments
11.6 FANGMING
11.6.1 FANGMING Company Information
11.6.2 FANGMING Piroxicam Product Offered
11.6.3 FANGMING Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 FANGMING Main Business Overview
11.6.5 FANGMING Latest Developments
11.7 JINGHUA
11.7.1 JINGHUA Company Information
11.7.2 JINGHUA Piroxicam Product Offered
11.7.3 JINGHUA Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 JINGHUA Main Business Overview
11.7.5 JINGHUA Latest Developments
11.8 JUMPCAN
11.8.1 JUMPCAN Company Information
11.8.2 JUMPCAN Piroxicam Product Offered
11.8.3 JUMPCAN Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 JUMPCAN Main Business Overview
11.8.5 JUMPCAN Latest Developments
11.9 Technilab Pharma
11.9.1 Technilab Pharma Company Information
11.9.2 Technilab Pharma Piroxicam Product Offered
11.9.3 Technilab Pharma Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Technilab Pharma Main Business Overview
11.9.5 Technilab Pharma Latest Developments
11.10 Apotex Corporation
11.10.1 Apotex Corporation Company Information
11.10.2 Apotex Corporation Piroxicam Product Offered
11.10.3 Apotex Corporation Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Apotex Corporation Main Business Overview
11.10.5 Apotex Corporation Latest Developments
11.11 Keltman Pharmaceuticals
11.11.1 Keltman Pharmaceuticals Company Information
11.11.2 Keltman Pharmaceuticals Piroxicam Product Offered
11.11.3 Keltman Pharmaceuticals Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Keltman Pharmaceuticals Main Business Overview
11.11.5 Keltman Pharmaceuticals Latest Developments
11.12 Genpharm
11.12.1 Genpharm Company Information
11.12.2 Genpharm Piroxicam Product Offered
11.12.3 Genpharm Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Genpharm Main Business Overview
11.12.5 Genpharm Latest Developments
11.13 Bayer
11.13.1 Bayer Company Information
11.13.2 Bayer Piroxicam Product Offered
11.13.3 Bayer Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Bayer Main Business Overview
11.13.5 Bayer Latest Developments
11.14 PLX Pharma
11.14.1 PLX Pharma Company Information
11.14.2 PLX Pharma Piroxicam Product Offered
11.14.3 PLX Pharma Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 PLX Pharma Main Business Overview
11.14.5 PLX Pharma Latest Developments
11.15 Chiesi
11.15.1 Chiesi Company Information
11.15.2 Chiesi Piroxicam Product Offered
11.15.3 Chiesi Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Chiesi Main Business Overview
11.15.5 Chiesi Latest Developments
11.16 SK Chemicals
11.16.1 SK Chemicals Company Information
11.16.2 SK Chemicals Piroxicam Product Offered
11.16.3 SK Chemicals Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 SK Chemicals Main Business Overview
11.16.5 SK Chemicals Latest Developments
11.17 Bioglan Laboratories
11.17.1 Bioglan Laboratories Company Information
11.17.2 Bioglan Laboratories Piroxicam Product Offered
11.17.3 Bioglan Laboratories Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Bioglan Laboratories Main Business Overview
11.17.5 Bioglan Laboratories Latest Developments
11.18 APR
11.18.1 APR Company Information
11.18.2 APR Piroxicam Product Offered
11.18.3 APR Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 APR Main Business Overview
11.18.5 APR Latest Developments
11.19 CJ HealthCare
11.19.1 CJ HealthCare Company Information
11.19.2 CJ HealthCare Piroxicam Product Offered
11.19.3 CJ HealthCare Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 CJ HealthCare Main Business Overview
11.19.5 CJ HealthCare Latest Developments
11.20 SkyePharma
11.20.1 SkyePharma Company Information
11.20.2 SkyePharma Piroxicam Product Offered
11.20.3 SkyePharma Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 SkyePharma Main Business Overview
11.20.5 SkyePharma Latest Developments
11.21 Changzhou Siyao Pharmaceutical
11.21.1 Changzhou Siyao Pharmaceutical Company Information
11.21.2 Changzhou Siyao Pharmaceutical Piroxicam Product Offered
11.21.3 Changzhou Siyao Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Changzhou Siyao Pharmaceutical Main Business Overview
11.21.5 Changzhou Siyao Pharmaceutical Latest Developments
11.22 Shanxi Yunpeng Pharmaceutical
11.22.1 Shanxi Yunpeng Pharmaceutical Company Information
11.22.2 Shanxi Yunpeng Pharmaceutical Piroxicam Product Offered
11.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Shanxi Yunpeng Pharmaceutical Main Business Overview
11.22.5 Shanxi Yunpeng Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Piroxicam Market Size (2020-2031)
2.1.2 Piroxicam Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Piroxicam by Country/Region (2020, 2024 & 2031)
2.2 Piroxicam Segment by Type
2.2.1 by Dosage Form
2.2.2 by Route
2.3 Piroxicam Market Size by Type
2.3.1 Piroxicam Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Piroxicam Market Size Market Share by Type (2020-2025)
2.4 Piroxicam Segment by Application
2.4.1 Tendonitis
2.4.2 Systemic Traumatic Pain
2.4.3 Musculoskeletal Pain
2.4.4 Contraception
2.4.5 Rheumatoid Arthritis
2.4.6 Chronic Infectious Arthritis
2.4.7 Osteoarthritis
2.4.8 Other
2.5 Piroxicam Market Size by Application
2.5.1 Piroxicam Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Piroxicam Market Size Market Share by Application (2020-2025)
3 PIROXICAM MARKET SIZE BY PLAYER
3.1 Piroxicam Market Size Market Share by Player
3.1.1 Global Piroxicam Revenue by Player (2020-2025)
3.1.2 Global Piroxicam Revenue Market Share by Player (2020-2025)
3.2 Global Piroxicam Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PIROXICAM BY REGION
4.1 Piroxicam Market Size by Region (2020-2025)
4.2 Global Piroxicam Annual Revenue by Country/Region (2020-2025)
4.3 Americas Piroxicam Market Size Growth (2020-2025)
4.4 APAC Piroxicam Market Size Growth (2020-2025)
4.5 Europe Piroxicam Market Size Growth (2020-2025)
4.6 Middle East & Africa Piroxicam Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Piroxicam Market Size by Country (2020-2025)
5.2 Americas Piroxicam Market Size by Type (2020-2025)
5.3 Americas Piroxicam Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Piroxicam Market Size by Region (2020-2025)
6.2 APAC Piroxicam Market Size by Type (2020-2025)
6.3 APAC Piroxicam Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Piroxicam Market Size by Country (2020-2025)
7.2 Europe Piroxicam Market Size by Type (2020-2025)
7.3 Europe Piroxicam Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Piroxicam by Region (2020-2025)
8.2 Middle East & Africa Piroxicam Market Size by Type (2020-2025)
8.3 Middle East & Africa Piroxicam Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PIROXICAM MARKET FORECAST
10.1 Global Piroxicam Forecast by Region (2026-2031)
10.1.1 Global Piroxicam Forecast by Region (2026-2031)
10.1.2 Americas Piroxicam Forecast
10.1.3 APAC Piroxicam Forecast
10.1.4 Europe Piroxicam Forecast
10.1.5 Middle East & Africa Piroxicam Forecast
10.2 Americas Piroxicam Forecast by Country (2026-2031)
10.2.1 United States Market Piroxicam Forecast
10.2.2 Canada Market Piroxicam Forecast
10.2.3 Mexico Market Piroxicam Forecast
10.2.4 Brazil Market Piroxicam Forecast
10.3 APAC Piroxicam Forecast by Region (2026-2031)
10.3.1 China Piroxicam Market Forecast
10.3.2 Japan Market Piroxicam Forecast
10.3.3 Korea Market Piroxicam Forecast
10.3.4 Southeast Asia Market Piroxicam Forecast
10.3.5 India Market Piroxicam Forecast
10.3.6 Australia Market Piroxicam Forecast
10.4 Europe Piroxicam Forecast by Country (2026-2031)
10.4.1 Germany Market Piroxicam Forecast
10.4.2 France Market Piroxicam Forecast
10.4.3 UK Market Piroxicam Forecast
10.4.4 Italy Market Piroxicam Forecast
10.4.5 Russia Market Piroxicam Forecast
10.5 Middle East & Africa Piroxicam Forecast by Region (2026-2031)
10.5.1 Egypt Market Piroxicam Forecast
10.5.2 South Africa Market Piroxicam Forecast
10.5.3 Israel Market Piroxicam Forecast
10.5.4 Turkey Market Piroxicam Forecast
10.6 Global Piroxicam Forecast by Type (2026-2031)
10.7 Global Piroxicam Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Piroxicam Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Piroxicam Product Offered
11.1.3 Pfizer Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Piroxicam Product Offered
11.2.3 Teva Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Piroxicam Product Offered
11.3.3 Mylan Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Nostrum
11.4.1 Nostrum Company Information
11.4.2 Nostrum Piroxicam Product Offered
11.4.3 Nostrum Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Nostrum Main Business Overview
11.4.5 Nostrum Latest Developments
11.5 DCPC
11.5.1 DCPC Company Information
11.5.2 DCPC Piroxicam Product Offered
11.5.3 DCPC Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 DCPC Main Business Overview
11.5.5 DCPC Latest Developments
11.6 FANGMING
11.6.1 FANGMING Company Information
11.6.2 FANGMING Piroxicam Product Offered
11.6.3 FANGMING Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 FANGMING Main Business Overview
11.6.5 FANGMING Latest Developments
11.7 JINGHUA
11.7.1 JINGHUA Company Information
11.7.2 JINGHUA Piroxicam Product Offered
11.7.3 JINGHUA Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 JINGHUA Main Business Overview
11.7.5 JINGHUA Latest Developments
11.8 JUMPCAN
11.8.1 JUMPCAN Company Information
11.8.2 JUMPCAN Piroxicam Product Offered
11.8.3 JUMPCAN Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 JUMPCAN Main Business Overview
11.8.5 JUMPCAN Latest Developments
11.9 Technilab Pharma
11.9.1 Technilab Pharma Company Information
11.9.2 Technilab Pharma Piroxicam Product Offered
11.9.3 Technilab Pharma Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Technilab Pharma Main Business Overview
11.9.5 Technilab Pharma Latest Developments
11.10 Apotex Corporation
11.10.1 Apotex Corporation Company Information
11.10.2 Apotex Corporation Piroxicam Product Offered
11.10.3 Apotex Corporation Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Apotex Corporation Main Business Overview
11.10.5 Apotex Corporation Latest Developments
11.11 Keltman Pharmaceuticals
11.11.1 Keltman Pharmaceuticals Company Information
11.11.2 Keltman Pharmaceuticals Piroxicam Product Offered
11.11.3 Keltman Pharmaceuticals Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Keltman Pharmaceuticals Main Business Overview
11.11.5 Keltman Pharmaceuticals Latest Developments
11.12 Genpharm
11.12.1 Genpharm Company Information
11.12.2 Genpharm Piroxicam Product Offered
11.12.3 Genpharm Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Genpharm Main Business Overview
11.12.5 Genpharm Latest Developments
11.13 Bayer
11.13.1 Bayer Company Information
11.13.2 Bayer Piroxicam Product Offered
11.13.3 Bayer Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Bayer Main Business Overview
11.13.5 Bayer Latest Developments
11.14 PLX Pharma
11.14.1 PLX Pharma Company Information
11.14.2 PLX Pharma Piroxicam Product Offered
11.14.3 PLX Pharma Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 PLX Pharma Main Business Overview
11.14.5 PLX Pharma Latest Developments
11.15 Chiesi
11.15.1 Chiesi Company Information
11.15.2 Chiesi Piroxicam Product Offered
11.15.3 Chiesi Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Chiesi Main Business Overview
11.15.5 Chiesi Latest Developments
11.16 SK Chemicals
11.16.1 SK Chemicals Company Information
11.16.2 SK Chemicals Piroxicam Product Offered
11.16.3 SK Chemicals Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 SK Chemicals Main Business Overview
11.16.5 SK Chemicals Latest Developments
11.17 Bioglan Laboratories
11.17.1 Bioglan Laboratories Company Information
11.17.2 Bioglan Laboratories Piroxicam Product Offered
11.17.3 Bioglan Laboratories Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Bioglan Laboratories Main Business Overview
11.17.5 Bioglan Laboratories Latest Developments
11.18 APR
11.18.1 APR Company Information
11.18.2 APR Piroxicam Product Offered
11.18.3 APR Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 APR Main Business Overview
11.18.5 APR Latest Developments
11.19 CJ HealthCare
11.19.1 CJ HealthCare Company Information
11.19.2 CJ HealthCare Piroxicam Product Offered
11.19.3 CJ HealthCare Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 CJ HealthCare Main Business Overview
11.19.5 CJ HealthCare Latest Developments
11.20 SkyePharma
11.20.1 SkyePharma Company Information
11.20.2 SkyePharma Piroxicam Product Offered
11.20.3 SkyePharma Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 SkyePharma Main Business Overview
11.20.5 SkyePharma Latest Developments
11.21 Changzhou Siyao Pharmaceutical
11.21.1 Changzhou Siyao Pharmaceutical Company Information
11.21.2 Changzhou Siyao Pharmaceutical Piroxicam Product Offered
11.21.3 Changzhou Siyao Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Changzhou Siyao Pharmaceutical Main Business Overview
11.21.5 Changzhou Siyao Pharmaceutical Latest Developments
11.22 Shanxi Yunpeng Pharmaceutical
11.22.1 Shanxi Yunpeng Pharmaceutical Company Information
11.22.2 Shanxi Yunpeng Pharmaceutical Piroxicam Product Offered
11.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Shanxi Yunpeng Pharmaceutical Main Business Overview
11.22.5 Shanxi Yunpeng Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Piroxicam Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Piroxicam Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of by Dosage Form
Table 4. Major Players of by Route
Table 5. Piroxicam Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Piroxicam Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Piroxicam Market Size Market Share by Type (2020-2025)
Table 8. Piroxicam Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Piroxicam Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Piroxicam Market Size Market Share by Application (2020-2025)
Table 11. Global Piroxicam Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Piroxicam Revenue Market Share by Player (2020-2025)
Table 13. Piroxicam Key Players Head office and Products Offered
Table 14. Piroxicam Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Piroxicam Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Piroxicam Market Size Market Share by Region (2020-2025)
Table 19. Global Piroxicam Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Piroxicam Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Piroxicam Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Piroxicam Market Size Market Share by Country (2020-2025)
Table 23. Americas Piroxicam Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Piroxicam Market Size Market Share by Type (2020-2025)
Table 25. Americas Piroxicam Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Piroxicam Market Size Market Share by Application (2020-2025)
Table 27. APAC Piroxicam Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Piroxicam Market Size Market Share by Region (2020-2025)
Table 29. APAC Piroxicam Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Piroxicam Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Piroxicam Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Piroxicam Market Size Market Share by Country (2020-2025)
Table 33. Europe Piroxicam Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Piroxicam Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Piroxicam Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Piroxicam Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Piroxicam Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Piroxicam
Table 39. Key Market Challenges & Risks of Piroxicam
Table 40. Key Industry Trends of Piroxicam
Table 41. Global Piroxicam Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Piroxicam Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Piroxicam Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Piroxicam Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Pfizer Details, Company Type, Piroxicam Area Served and Its Competitors
Table 46. Pfizer Piroxicam Product Offered
Table 47. Pfizer Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Pfizer Main Business
Table 49. Pfizer Latest Developments
Table 50. Teva Details, Company Type, Piroxicam Area Served and Its Competitors
Table 51. Teva Piroxicam Product Offered
Table 52. Teva Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Teva Main Business
Table 54. Teva Latest Developments
Table 55. Mylan Details, Company Type, Piroxicam Area Served and Its Competitors
Table 56. Mylan Piroxicam Product Offered
Table 57. Mylan Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Mylan Main Business
Table 59. Mylan Latest Developments
Table 60. Nostrum Details, Company Type, Piroxicam Area Served and Its Competitors
Table 61. Nostrum Piroxicam Product Offered
Table 62. Nostrum Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Nostrum Main Business
Table 64. Nostrum Latest Developments
Table 65. DCPC Details, Company Type, Piroxicam Area Served and Its Competitors
Table 66. DCPC Piroxicam Product Offered
Table 67. DCPC Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. DCPC Main Business
Table 69. DCPC Latest Developments
Table 70. FANGMING Details, Company Type, Piroxicam Area Served and Its Competitors
Table 71. FANGMING Piroxicam Product Offered
Table 72. FANGMING Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. FANGMING Main Business
Table 74. FANGMING Latest Developments
Table 75. JINGHUA Details, Company Type, Piroxicam Area Served and Its Competitors
Table 76. JINGHUA Piroxicam Product Offered
Table 77. JINGHUA Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. JINGHUA Main Business
Table 79. JINGHUA Latest Developments
Table 80. JUMPCAN Details, Company Type, Piroxicam Area Served and Its Competitors
Table 81. JUMPCAN Piroxicam Product Offered
Table 82. JUMPCAN Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. JUMPCAN Main Business
Table 84. JUMPCAN Latest Developments
Table 85. Technilab Pharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 86. Technilab Pharma Piroxicam Product Offered
Table 87. Technilab Pharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Technilab Pharma Main Business
Table 89. Technilab Pharma Latest Developments
Table 90. Apotex Corporation Details, Company Type, Piroxicam Area Served and Its Competitors
Table 91. Apotex Corporation Piroxicam Product Offered
Table 92. Apotex Corporation Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Apotex Corporation Main Business
Table 94. Apotex Corporation Latest Developments
Table 95. Keltman Pharmaceuticals Details, Company Type, Piroxicam Area Served and Its Competitors
Table 96. Keltman Pharmaceuticals Piroxicam Product Offered
Table 97. Keltman Pharmaceuticals Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Keltman Pharmaceuticals Main Business
Table 99. Keltman Pharmaceuticals Latest Developments
Table 100. Genpharm Details, Company Type, Piroxicam Area Served and Its Competitors
Table 101. Genpharm Piroxicam Product Offered
Table 102. Genpharm Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Genpharm Main Business
Table 104. Genpharm Latest Developments
Table 105. Bayer Details, Company Type, Piroxicam Area Served and Its Competitors
Table 106. Bayer Piroxicam Product Offered
Table 107. Bayer Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Bayer Main Business
Table 109. Bayer Latest Developments
Table 110. PLX Pharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 111. PLX Pharma Piroxicam Product Offered
Table 112. PLX Pharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. PLX Pharma Main Business
Table 114. PLX Pharma Latest Developments
Table 115. Chiesi Details, Company Type, Piroxicam Area Served and Its Competitors
Table 116. Chiesi Piroxicam Product Offered
Table 117. Chiesi Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Chiesi Main Business
Table 119. Chiesi Latest Developments
Table 120. SK Chemicals Details, Company Type, Piroxicam Area Served and Its Competitors
Table 121. SK Chemicals Piroxicam Product Offered
Table 122. SK Chemicals Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. SK Chemicals Main Business
Table 124. SK Chemicals Latest Developments
Table 125. Bioglan Laboratories Details, Company Type, Piroxicam Area Served and Its Competitors
Table 126. Bioglan Laboratories Piroxicam Product Offered
Table 127. Bioglan Laboratories Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Bioglan Laboratories Main Business
Table 129. Bioglan Laboratories Latest Developments
Table 130. APR Details, Company Type, Piroxicam Area Served and Its Competitors
Table 131. APR Piroxicam Product Offered
Table 132. APR Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. APR Main Business
Table 134. APR Latest Developments
Table 135. CJ HealthCare Details, Company Type, Piroxicam Area Served and Its Competitors
Table 136. CJ HealthCare Piroxicam Product Offered
Table 137. CJ HealthCare Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. CJ HealthCare Main Business
Table 139. CJ HealthCare Latest Developments
Table 140. SkyePharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 141. SkyePharma Piroxicam Product Offered
Table 142. SkyePharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. SkyePharma Main Business
Table 144. SkyePharma Latest Developments
Table 145. Changzhou Siyao Pharmaceutical Details, Company Type, Piroxicam Area Served and Its Competitors
Table 146. Changzhou Siyao Pharmaceutical Piroxicam Product Offered
Table 147. Changzhou Siyao Pharmaceutical Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Changzhou Siyao Pharmaceutical Main Business
Table 149. Changzhou Siyao Pharmaceutical Latest Developments
Table 150. Shanxi Yunpeng Pharmaceutical Details, Company Type, Piroxicam Area Served and Its Competitors
Table 151. Shanxi Yunpeng Pharmaceutical Piroxicam Product Offered
Table 152. Shanxi Yunpeng Pharmaceutical Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. Shanxi Yunpeng Pharmaceutical Main Business
Table 154. Shanxi Yunpeng Pharmaceutical Latest Developments
Table 1. Piroxicam Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Piroxicam Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of by Dosage Form
Table 4. Major Players of by Route
Table 5. Piroxicam Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Piroxicam Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Piroxicam Market Size Market Share by Type (2020-2025)
Table 8. Piroxicam Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Piroxicam Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Piroxicam Market Size Market Share by Application (2020-2025)
Table 11. Global Piroxicam Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Piroxicam Revenue Market Share by Player (2020-2025)
Table 13. Piroxicam Key Players Head office and Products Offered
Table 14. Piroxicam Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Piroxicam Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Piroxicam Market Size Market Share by Region (2020-2025)
Table 19. Global Piroxicam Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Piroxicam Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Piroxicam Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Piroxicam Market Size Market Share by Country (2020-2025)
Table 23. Americas Piroxicam Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Piroxicam Market Size Market Share by Type (2020-2025)
Table 25. Americas Piroxicam Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Piroxicam Market Size Market Share by Application (2020-2025)
Table 27. APAC Piroxicam Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Piroxicam Market Size Market Share by Region (2020-2025)
Table 29. APAC Piroxicam Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Piroxicam Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Piroxicam Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Piroxicam Market Size Market Share by Country (2020-2025)
Table 33. Europe Piroxicam Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Piroxicam Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Piroxicam Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Piroxicam Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Piroxicam Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Piroxicam
Table 39. Key Market Challenges & Risks of Piroxicam
Table 40. Key Industry Trends of Piroxicam
Table 41. Global Piroxicam Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Piroxicam Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Piroxicam Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Piroxicam Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Pfizer Details, Company Type, Piroxicam Area Served and Its Competitors
Table 46. Pfizer Piroxicam Product Offered
Table 47. Pfizer Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Pfizer Main Business
Table 49. Pfizer Latest Developments
Table 50. Teva Details, Company Type, Piroxicam Area Served and Its Competitors
Table 51. Teva Piroxicam Product Offered
Table 52. Teva Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Teva Main Business
Table 54. Teva Latest Developments
Table 55. Mylan Details, Company Type, Piroxicam Area Served and Its Competitors
Table 56. Mylan Piroxicam Product Offered
Table 57. Mylan Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Mylan Main Business
Table 59. Mylan Latest Developments
Table 60. Nostrum Details, Company Type, Piroxicam Area Served and Its Competitors
Table 61. Nostrum Piroxicam Product Offered
Table 62. Nostrum Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Nostrum Main Business
Table 64. Nostrum Latest Developments
Table 65. DCPC Details, Company Type, Piroxicam Area Served and Its Competitors
Table 66. DCPC Piroxicam Product Offered
Table 67. DCPC Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. DCPC Main Business
Table 69. DCPC Latest Developments
Table 70. FANGMING Details, Company Type, Piroxicam Area Served and Its Competitors
Table 71. FANGMING Piroxicam Product Offered
Table 72. FANGMING Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. FANGMING Main Business
Table 74. FANGMING Latest Developments
Table 75. JINGHUA Details, Company Type, Piroxicam Area Served and Its Competitors
Table 76. JINGHUA Piroxicam Product Offered
Table 77. JINGHUA Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. JINGHUA Main Business
Table 79. JINGHUA Latest Developments
Table 80. JUMPCAN Details, Company Type, Piroxicam Area Served and Its Competitors
Table 81. JUMPCAN Piroxicam Product Offered
Table 82. JUMPCAN Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. JUMPCAN Main Business
Table 84. JUMPCAN Latest Developments
Table 85. Technilab Pharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 86. Technilab Pharma Piroxicam Product Offered
Table 87. Technilab Pharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Technilab Pharma Main Business
Table 89. Technilab Pharma Latest Developments
Table 90. Apotex Corporation Details, Company Type, Piroxicam Area Served and Its Competitors
Table 91. Apotex Corporation Piroxicam Product Offered
Table 92. Apotex Corporation Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Apotex Corporation Main Business
Table 94. Apotex Corporation Latest Developments
Table 95. Keltman Pharmaceuticals Details, Company Type, Piroxicam Area Served and Its Competitors
Table 96. Keltman Pharmaceuticals Piroxicam Product Offered
Table 97. Keltman Pharmaceuticals Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Keltman Pharmaceuticals Main Business
Table 99. Keltman Pharmaceuticals Latest Developments
Table 100. Genpharm Details, Company Type, Piroxicam Area Served and Its Competitors
Table 101. Genpharm Piroxicam Product Offered
Table 102. Genpharm Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Genpharm Main Business
Table 104. Genpharm Latest Developments
Table 105. Bayer Details, Company Type, Piroxicam Area Served and Its Competitors
Table 106. Bayer Piroxicam Product Offered
Table 107. Bayer Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Bayer Main Business
Table 109. Bayer Latest Developments
Table 110. PLX Pharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 111. PLX Pharma Piroxicam Product Offered
Table 112. PLX Pharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. PLX Pharma Main Business
Table 114. PLX Pharma Latest Developments
Table 115. Chiesi Details, Company Type, Piroxicam Area Served and Its Competitors
Table 116. Chiesi Piroxicam Product Offered
Table 117. Chiesi Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Chiesi Main Business
Table 119. Chiesi Latest Developments
Table 120. SK Chemicals Details, Company Type, Piroxicam Area Served and Its Competitors
Table 121. SK Chemicals Piroxicam Product Offered
Table 122. SK Chemicals Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. SK Chemicals Main Business
Table 124. SK Chemicals Latest Developments
Table 125. Bioglan Laboratories Details, Company Type, Piroxicam Area Served and Its Competitors
Table 126. Bioglan Laboratories Piroxicam Product Offered
Table 127. Bioglan Laboratories Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Bioglan Laboratories Main Business
Table 129. Bioglan Laboratories Latest Developments
Table 130. APR Details, Company Type, Piroxicam Area Served and Its Competitors
Table 131. APR Piroxicam Product Offered
Table 132. APR Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. APR Main Business
Table 134. APR Latest Developments
Table 135. CJ HealthCare Details, Company Type, Piroxicam Area Served and Its Competitors
Table 136. CJ HealthCare Piroxicam Product Offered
Table 137. CJ HealthCare Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. CJ HealthCare Main Business
Table 139. CJ HealthCare Latest Developments
Table 140. SkyePharma Details, Company Type, Piroxicam Area Served and Its Competitors
Table 141. SkyePharma Piroxicam Product Offered
Table 142. SkyePharma Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. SkyePharma Main Business
Table 144. SkyePharma Latest Developments
Table 145. Changzhou Siyao Pharmaceutical Details, Company Type, Piroxicam Area Served and Its Competitors
Table 146. Changzhou Siyao Pharmaceutical Piroxicam Product Offered
Table 147. Changzhou Siyao Pharmaceutical Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Changzhou Siyao Pharmaceutical Main Business
Table 149. Changzhou Siyao Pharmaceutical Latest Developments
Table 150. Shanxi Yunpeng Pharmaceutical Details, Company Type, Piroxicam Area Served and Its Competitors
Table 151. Shanxi Yunpeng Pharmaceutical Piroxicam Product Offered
Table 152. Shanxi Yunpeng Pharmaceutical Piroxicam Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. Shanxi Yunpeng Pharmaceutical Main Business
Table 154. Shanxi Yunpeng Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Piroxicam Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Piroxicam Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Piroxicam Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Piroxicam Sales Market Share by Country/Region (2024)
Figure 8. Piroxicam Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Piroxicam Market Size Market Share by Type in 2024
Figure 10. Piroxicam in Tendonitis
Figure 11. Global Piroxicam Market: Tendonitis (2020-2025) & ($ millions)
Figure 12. Piroxicam in Systemic Traumatic Pain
Figure 13. Global Piroxicam Market: Systemic Traumatic Pain (2020-2025) & ($ millions)
Figure 14. Piroxicam in Musculoskeletal Pain
Figure 15. Global Piroxicam Market: Musculoskeletal Pain (2020-2025) & ($ millions)
Figure 16. Piroxicam in Contraception
Figure 17. Global Piroxicam Market: Contraception (2020-2025) & ($ millions)
Figure 18. Piroxicam in Rheumatoid Arthritis
Figure 19. Global Piroxicam Market: Rheumatoid Arthritis (2020-2025) & ($ millions)
Figure 20. Piroxicam in Chronic Infectious Arthritis
Figure 21. Global Piroxicam Market: Chronic Infectious Arthritis (2020-2025) & ($ millions)
Figure 22. Piroxicam in Osteoarthritis
Figure 23. Global Piroxicam Market: Osteoarthritis (2020-2025) & ($ millions)
Figure 24. Piroxicam in Other
Figure 25. Global Piroxicam Market: Other (2020-2025) & ($ millions)
Figure 26. Global Piroxicam Market Size Market Share by Application in 2024
Figure 27. Global Piroxicam Revenue Market Share by Player in 2024
Figure 28. Global Piroxicam Market Size Market Share by Region (2020-2025)
Figure 29. Americas Piroxicam Market Size 2020-2025 ($ millions)
Figure 30. APAC Piroxicam Market Size 2020-2025 ($ millions)
Figure 31. Europe Piroxicam Market Size 2020-2025 ($ millions)
Figure 32. Middle East & Africa Piroxicam Market Size 2020-2025 ($ millions)
Figure 33. Americas Piroxicam Value Market Share by Country in 2024
Figure 34. United States Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 35. Canada Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 36. Mexico Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 37. Brazil Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 38. APAC Piroxicam Market Size Market Share by Region in 2024
Figure 39. APAC Piroxicam Market Size Market Share by Type (2020-2025)
Figure 40. APAC Piroxicam Market Size Market Share by Application (2020-2025)
Figure 41. China Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 42. Japan Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 43. South Korea Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 44. Southeast Asia Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 45. India Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 46. Australia Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 47. Europe Piroxicam Market Size Market Share by Country in 2024
Figure 48. Europe Piroxicam Market Size Market Share by Type (2020-2025)
Figure 49. Europe Piroxicam Market Size Market Share by Application (2020-2025)
Figure 50. Germany Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 51. France Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 52. UK Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 53. Italy Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 54. Russia Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 55. Middle East & Africa Piroxicam Market Size Market Share by Region (2020-2025)
Figure 56. Middle East & Africa Piroxicam Market Size Market Share by Type (2020-2025)
Figure 57. Middle East & Africa Piroxicam Market Size Market Share by Application (2020-2025)
Figure 58. Egypt Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 59. South Africa Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 60. Israel Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 61. Turkey Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 62. GCC Countries Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 63. Americas Piroxicam Market Size 2026-2031 ($ millions)
Figure 64. APAC Piroxicam Market Size 2026-2031 ($ millions)
Figure 65. Europe Piroxicam Market Size 2026-2031 ($ millions)
Figure 66. Middle East & Africa Piroxicam Market Size 2026-2031 ($ millions)
Figure 67. United States Piroxicam Market Size 2026-2031 ($ millions)
Figure 68. Canada Piroxicam Market Size 2026-2031 ($ millions)
Figure 69. Mexico Piroxicam Market Size 2026-2031 ($ millions)
Figure 70. Brazil Piroxicam Market Size 2026-2031 ($ millions)
Figure 71. China Piroxicam Market Size 2026-2031 ($ millions)
Figure 72. Japan Piroxicam Market Size 2026-2031 ($ millions)
Figure 73. Korea Piroxicam Market Size 2026-2031 ($ millions)
Figure 74. Southeast Asia Piroxicam Market Size 2026-2031 ($ millions)
Figure 75. India Piroxicam Market Size 2026-2031 ($ millions)
Figure 76. Australia Piroxicam Market Size 2026-2031 ($ millions)
Figure 77. Germany Piroxicam Market Size 2026-2031 ($ millions)
Figure 78. France Piroxicam Market Size 2026-2031 ($ millions)
Figure 79. UK Piroxicam Market Size 2026-2031 ($ millions)
Figure 80. Italy Piroxicam Market Size 2026-2031 ($ millions)
Figure 81. Russia Piroxicam Market Size 2026-2031 ($ millions)
Figure 82. Egypt Piroxicam Market Size 2026-2031 ($ millions)
Figure 83. South Africa Piroxicam Market Size 2026-2031 ($ millions)
Figure 84. Israel Piroxicam Market Size 2026-2031 ($ millions)
Figure 85. Turkey Piroxicam Market Size 2026-2031 ($ millions)
Figure 86. Global Piroxicam Market Size Market Share Forecast by Type (2026-2031)
Figure 87. Global Piroxicam Market Size Market Share Forecast by Application (2026-2031)
Figure 88. GCC Countries Piroxicam Market Size 2026-2031 ($ millions)
Figure 1. Piroxicam Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Piroxicam Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Piroxicam Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Piroxicam Sales Market Share by Country/Region (2024)
Figure 8. Piroxicam Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Piroxicam Market Size Market Share by Type in 2024
Figure 10. Piroxicam in Tendonitis
Figure 11. Global Piroxicam Market: Tendonitis (2020-2025) & ($ millions)
Figure 12. Piroxicam in Systemic Traumatic Pain
Figure 13. Global Piroxicam Market: Systemic Traumatic Pain (2020-2025) & ($ millions)
Figure 14. Piroxicam in Musculoskeletal Pain
Figure 15. Global Piroxicam Market: Musculoskeletal Pain (2020-2025) & ($ millions)
Figure 16. Piroxicam in Contraception
Figure 17. Global Piroxicam Market: Contraception (2020-2025) & ($ millions)
Figure 18. Piroxicam in Rheumatoid Arthritis
Figure 19. Global Piroxicam Market: Rheumatoid Arthritis (2020-2025) & ($ millions)
Figure 20. Piroxicam in Chronic Infectious Arthritis
Figure 21. Global Piroxicam Market: Chronic Infectious Arthritis (2020-2025) & ($ millions)
Figure 22. Piroxicam in Osteoarthritis
Figure 23. Global Piroxicam Market: Osteoarthritis (2020-2025) & ($ millions)
Figure 24. Piroxicam in Other
Figure 25. Global Piroxicam Market: Other (2020-2025) & ($ millions)
Figure 26. Global Piroxicam Market Size Market Share by Application in 2024
Figure 27. Global Piroxicam Revenue Market Share by Player in 2024
Figure 28. Global Piroxicam Market Size Market Share by Region (2020-2025)
Figure 29. Americas Piroxicam Market Size 2020-2025 ($ millions)
Figure 30. APAC Piroxicam Market Size 2020-2025 ($ millions)
Figure 31. Europe Piroxicam Market Size 2020-2025 ($ millions)
Figure 32. Middle East & Africa Piroxicam Market Size 2020-2025 ($ millions)
Figure 33. Americas Piroxicam Value Market Share by Country in 2024
Figure 34. United States Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 35. Canada Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 36. Mexico Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 37. Brazil Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 38. APAC Piroxicam Market Size Market Share by Region in 2024
Figure 39. APAC Piroxicam Market Size Market Share by Type (2020-2025)
Figure 40. APAC Piroxicam Market Size Market Share by Application (2020-2025)
Figure 41. China Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 42. Japan Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 43. South Korea Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 44. Southeast Asia Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 45. India Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 46. Australia Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 47. Europe Piroxicam Market Size Market Share by Country in 2024
Figure 48. Europe Piroxicam Market Size Market Share by Type (2020-2025)
Figure 49. Europe Piroxicam Market Size Market Share by Application (2020-2025)
Figure 50. Germany Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 51. France Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 52. UK Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 53. Italy Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 54. Russia Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 55. Middle East & Africa Piroxicam Market Size Market Share by Region (2020-2025)
Figure 56. Middle East & Africa Piroxicam Market Size Market Share by Type (2020-2025)
Figure 57. Middle East & Africa Piroxicam Market Size Market Share by Application (2020-2025)
Figure 58. Egypt Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 59. South Africa Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 60. Israel Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 61. Turkey Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 62. GCC Countries Piroxicam Market Size Growth 2020-2025 ($ millions)
Figure 63. Americas Piroxicam Market Size 2026-2031 ($ millions)
Figure 64. APAC Piroxicam Market Size 2026-2031 ($ millions)
Figure 65. Europe Piroxicam Market Size 2026-2031 ($ millions)
Figure 66. Middle East & Africa Piroxicam Market Size 2026-2031 ($ millions)
Figure 67. United States Piroxicam Market Size 2026-2031 ($ millions)
Figure 68. Canada Piroxicam Market Size 2026-2031 ($ millions)
Figure 69. Mexico Piroxicam Market Size 2026-2031 ($ millions)
Figure 70. Brazil Piroxicam Market Size 2026-2031 ($ millions)
Figure 71. China Piroxicam Market Size 2026-2031 ($ millions)
Figure 72. Japan Piroxicam Market Size 2026-2031 ($ millions)
Figure 73. Korea Piroxicam Market Size 2026-2031 ($ millions)
Figure 74. Southeast Asia Piroxicam Market Size 2026-2031 ($ millions)
Figure 75. India Piroxicam Market Size 2026-2031 ($ millions)
Figure 76. Australia Piroxicam Market Size 2026-2031 ($ millions)
Figure 77. Germany Piroxicam Market Size 2026-2031 ($ millions)
Figure 78. France Piroxicam Market Size 2026-2031 ($ millions)
Figure 79. UK Piroxicam Market Size 2026-2031 ($ millions)
Figure 80. Italy Piroxicam Market Size 2026-2031 ($ millions)
Figure 81. Russia Piroxicam Market Size 2026-2031 ($ millions)
Figure 82. Egypt Piroxicam Market Size 2026-2031 ($ millions)
Figure 83. South Africa Piroxicam Market Size 2026-2031 ($ millions)
Figure 84. Israel Piroxicam Market Size 2026-2031 ($ millions)
Figure 85. Turkey Piroxicam Market Size 2026-2031 ($ millions)
Figure 86. Global Piroxicam Market Size Market Share Forecast by Type (2026-2031)
Figure 87. Global Piroxicam Market Size Market Share Forecast by Application (2026-2031)
Figure 88. GCC Countries Piroxicam Market Size 2026-2031 ($ millions)
More Publications
Global Preclinical Optical Imaging System Market Growth 2023-2029
US$ 3,660.00
March 2023
92 pages
Global Hepatitis B Therapeutics Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
92 pages
Global Veterinary Monitoring Devices Market Growth 2023-2029
US$ 3,660.00
February 2023
124 pages
Global Functional Service Provider (FSP) Clinical Research Organization Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
90 pages
Global Transcutaneous Bilirubinometer Market Growth 2024-2030
US$ 3,660.00
December 2024
120 pages
